Citations (94)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
John B. Edwards. (2010) Centralised faecal blood testing for both screening and pathology requests. Pathology 42:7, pages 700-704.
Read now
Read now
O. D. Jørgensen, O. Kronborg & C. Fenger. (1995) A Randomized Surveillance Study of Patients with Pedunculated and Small Sessile Tubular and Tubulovillous Adenomas: The Funen Adenoma Follow-up Study. Scandinavian Journal of Gastroenterology 30:7, pages 686-692.
Read now
Read now
E. Lindholm, B. Berglund, E. Haglind & J. Kewenter. (1995) Factors Associated with Participation in Screening for Colorectal Cancer with Faecal Occult Blood Testing. Scandinavian Journal of Gastroenterology 30:2, pages 171-176.
Read now
Read now
B. Møller Jensen, O. Kronborg & C. Fenger. (1992) Interval Cancers in Screening with Fecal Occult Blood Test for Colorectal Cancer. Scandinavian Journal of Gastroenterology 27:9, pages 779-782.
Read now
Read now
O. Kronborg, C. Fenger, J. Worm, S. A. Pedersen, J. Hem, K. Bertelsen & J. Qlsen. (1992) Causes of Death during the First 5 Years of a Randomized Trial of Mass Screening for Colorectal Cancer with Fecal Occult Blood Test. Scandinavian Journal of Gastroenterology 27:1, pages 47-52.
Read now
Read now
Ole Kronborg. (1991) Population Screening for Colorectal Cancer, the Goals and Means. Annals of Medicine 23:4, pages 373-379.
Read now
Read now
O. Kronborg, C. Fenger, J. Olsen, K. Bech & O. Søndergaard. (1989) Repeated Screening for Colorectal Cancer with Fecal Occult Blood Test: A Prospective Randomized Study at Funen, Denmark. Scandinavian Journal of Gastroenterology 24:5, pages 599-606.
Read now
Read now
Heikki J. Järvinen & J.-P. Mecklin. (1989) Screening for Hereditary Colorectal Carcinoma. Scandinavian Journal of Gastroenterology 24:10, pages 1153-1158.
Read now
Read now
Articles from other publishers (86)
Linda-Nicoleta Bărbulescu, Stelian-Ștefăniță Mogoantă, Lucian-Florentin Bărbulescu, Constantin Kamal, Didi-Liliana Popa & Radu-Teodoru Popa. (2023) A Pilot Colorectal Cancer Study Using Fecal Occult Blood Tests and Colonoscopy to Identify the Weaknesses of the Romanian Public Healthcare System before Implementing National Screening. International Journal of Environmental Research and Public Health 20:3, pages 2531.
Crossref
Crossref
Esmée J Grobbee, Pieter HA Wisse, Eline H Schreuders, Aafke van Roon, Leonie van Dam, Ann G Zauber, Iris Lansdorp-Vogelaar, Wichor Bramer, Sarah Berhane, Jonathan J Deeks, Ewout W Steyerberg, Monique E van Leerdam, Manon CW Spaander & Ernst J Kuipers. (2022) Guaiac-based faecal occult blood tests versus faecal immunochemical tests for colorectal cancer screening in average-risk individuals. Cochrane Database of Systematic Reviews 2022:6.
Crossref
Crossref
Jie-Bin Lew, Marjolein J. E. Greuter, Michael Caruana, Emily He, Joachim Worthington, D. James St John, Finlay A. Macrae, Eleonora Feletto, Veerle M. H. Coupé & Karen Canfell. (2020) Validation of Microsimulation Models against Alternative Model Predictions and Long-Term Colorectal Cancer Incidence and Mortality Outcomes of Randomized Controlled Trials. Medical Decision Making 40:6, pages 815-829.
Crossref
Crossref
Sarthak Soin, Olalekan Akanbi, Abdullah Ahmed, Yunha Kim, Sarbagya Pandit, Igor Wroblewski & Nasir Saleem. (2019) Use and abuse of fecal occult blood tests: a community hospital experience. BMC Gastroenterology 19:1.
Crossref
Crossref
A. T. George, S. Aggarwal, S. Dharmavaram, A. Menon, M. Dube, M. Vogler & A. Field. (2017) Faecal occult blood testing screening for colorectal cancer and ‘missed’ interval cancers: are we ignoring the elephant in the room? Results of a multicentre study. Colorectal Disease 19:5, pages O108-O114.
Crossref
Crossref
David Roder, Christos S Karapetis, David Wattchow, James Moore, Nimit Singhal, Rohit Joshi, Dorothy Keefe, Kellie Fusco, Dianne Buranyi-Trevarton, Greg Sharplin & Timothy J Price. (2015) Metastatic Colorectal Cancer Treatment and Survival: the Experience of Major Public Hospitals in South Australia Over Three Decades. Asian Pacific Journal of Cancer Prevention 16:14, pages 5923-5931.
Crossref
Crossref
David Roder, Christos S Karapetis, David Wattchow, James Moore, Nimit Singhal, Rohit Joshi, Dorothy Keefe, Kellie Fusco, Kate Powell, Marion Eckert & Timothy J Price. (2015) Colorectal Cancer Treatment and Survival: the Experience of Major Public Hospitals in South Australia over three Decades. Asian Pacific Journal of Cancer Prevention 16:6, pages 2431-2440.
Crossref
Crossref
Daniela E. Aust & Gustavo B. Baretton. 2013. Pathologie. Pathologie
611
661
.
M D Gill, M G Bramble, C J Rees, T J W Lee, D M Bradburn & S J Mills. (2012) Comparison of screen-detected and interval colorectal cancers in the Bowel Cancer Screening Programme. British Journal of Cancer 107:3, pages 417-421.
Crossref
Crossref
Tomasz Kozłowski, Dariusz Godlewski, Maciej Biczysko, Marcin Grochowalski, Marcin Nelke, Jacek Paszkowski, Maciej Borejsza-Wysocki, Łukasz Krokowicz, Piotr Krokowicz, Tomasz Banasiewicz & Michał Drews. (2011) Analysis of the Efficacy of Screening Tests in Colorectal Cancer by Faecal Occult Blood Test - Own Experience. Polish Journal of Surgery 83:8.
Crossref
Crossref
M. von Euler-Chelpin, K. Brasso & E. Lynge. (2009) Determinants of participation in colorectal cancer screening with faecal occult blood testing. Journal of Public Health 32:3, pages 395-405.
Crossref
Crossref
Philip C. Prorok & Pamela M. Marcus. (2010) Cancer Screening Trials: Nuts and Bolts. Seminars in Oncology 37:3, pages 216-223.
Crossref
Crossref
Kimberly W. Sanford & Richard A. McPherson. (2009) Fecal Occult Blood Testing. Clinics in Laboratory Medicine 29:3, pages 523-541.
Crossref
Crossref
. 2008. Surgery of the Anus, Rectum & Colon. Surgery of the Anus, Rectum & Colon
1029
1045
.
Carlos Torres, Samuel Szomstein & Steven D. Wexner. (2016) Virtual Colonoscopy in Colorectal Cancer Screening. Surgical Innovation 14:1, pages 27-34.
Crossref
Crossref
Michael R. Thompson, Robert J. C. Steele & W. S. Atkin. (2006) Effective Screening for Bowel Cancer: A United Kingdom Perspective. Diseases of the Colon & Rectum 49:6, pages 895-908.
Crossref
Crossref
W M Thomas, G Pye, J D Hardcastle & A R Walker. (1992) Screening for colorectal carcinoma: An analysis of the sensitivity of Haemoccult. British Journal of Surgery 79:8, pages 833-835.
Crossref
Crossref
M H E Robinson, O Kronborg, C B Williams, K Bostock, P S Rooney, L M Hunt & J D Hardcastle. (1995) Faecal occult blood testing and colonoscopy in the surveillance of subjects at high risk of colorectal neoplasia. British Journal of Surgery 82:3, pages 318-320.
Crossref
Crossref
M G Dunlop. (1992) Screening for large bowel neoplasms in individuals with a family history of colorectal cancer. British Journal of Surgery 79:6, pages 488-494.
Crossref
Crossref
G Pye, J Jackson, W M Thomas & J D Hardcastle. (1990) Comparison of coloscreen self-test® and Haemoccult® faecal occult blood tests in the detection of colorectal cancer in symptomatic patients. British Journal of Surgery 77:6, pages 630-631.
Crossref
Crossref
W M Thomas, G Pye, J D Hardcastle & C M Mangham. (1990) Faecal occult blood screening for colorectal neoplasia: A randomized trial of three days or six days of tests. British Journal of Surgery 77:3, pages 277-279.
Crossref
Crossref
W M Thomas, G Pye, J D Hardcastle, J Chamberlain & R M Charnley. (1989) Role of dietary restriction in Haemoccult® screening for colorectal cancer. British Journal of Surgery 76:9, pages 976-978.
Crossref
Crossref
M H E Robinson, C G Marks, P A Farrands, W M Thomas & J D Hardcastle. (1994) Population screening for colorectal cancer: Comparison between guaiac and immunological faecal occult blood tests. British Journal of Surgery 81:3, pages 448-451.
Crossref
Crossref
S M Caffarey, C I M Broughton & C G Marks. (1993) Faecal occult blood screening for colorectal neoplasia in a targeted high-risk population. British Journal of Surgery 80:11, pages 1399-1400.
Crossref
Crossref
S Bülow, L B Svendsen & A Mellemgaard. (1990) Metachronous colorectal carcinoma. British Journal of Surgery 77:5, pages 502-505.
Crossref
Crossref
Florian Froehlich & Jean‐Jacques Gonvers. 2003. Colonoscopy. Colonoscopy
111
130
.
. (2001) Screening for Colorectal Cancer. New England Journal of Medicine 345:25, pages 1850-1852.
Crossref
Crossref
P. Rogalla, N. Meiri & C. I. Bartram. 2001. Virtual Endoscopy and Related 3D Techniques. Virtual Endoscopy and Related 3D Techniques
101
157
.
Philip C. Prorok, Gerald L. Andriole, Robert S. Bresalier, Saundra S. Buys, David Chia, E. David Crawford, Ronald Fogel, Edward P. Gelmann, Fred Gilbert, Marsha A. Hasson, Richard B. Hayes, Christine Cole Johnson, Jack S. Mandel, Albert Oberman, Barbara O'Brien, Martin M. Oken, Sameer Rafla, Douglas Reding, Wilmer Rutt, Joel L. Weissfeld, Lance Yokochi & John K. Gohagan. (2000) Design of the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. Controlled Clinical Trials 21:6, pages 273S-309S.
Crossref
Crossref
V Bouvier, G Launoy, C Herbert, H Lefevre, J Maurel & M Gignoux. (1999) Colorectal cancer after a negative Haemoccult II® test and programme sensitivity after a first round of screening: The experience of the Department of Calvados (France). British Journal of Cancer 81:2, pages 305-309.
Crossref
Crossref
R J C Steele. (2016) Screening for Colorectal Cancer. Scottish Medical Journal 44:3, pages 67-67.
Crossref
Crossref
Robert J. C. Steele. (2016) Screening for Colorectal Cancer. Journal of Managed Care 1:3, pages 110-115.
Crossref
Crossref
D. P. Berry, P. Clarke, J. D. Hardcastle & K. D. Vellacott. (1997) Randomized trial of the addition of flexible sigmoidoscopy to faecal occult blood testing for colorectal neoplasia population screening. British Journal of Surgery 84:9, pages 1274-1276.
Crossref
Crossref
D. P. Berry, P. Clarke, J. D. Hardcastle & K. D. Vellacott. (1997) Randomized trial of the addition of flexible sigmoidoscopy to faecal occult blood testing for colorectal neoplasia population screening. British Journal of Surgery 84:9, pages 1274-1276.
Crossref
Crossref
Arnold J. Markowitz & Sidney J. Winawer. (1997) SCREENING AND SURVEILLANCE FOR COLORECTAL CARCINOMA. Hematology/Oncology Clinics of North America 11:4, pages 579-810.
Crossref
Crossref
Hidenori Nakama, Asm Abudl Fattah, Bing Zhang, Noboru Kamijo, Kazuya Fujimori & Kazunobu Miyata. (1997) Detection rate of immunochemical fecal occult blood test for colorectal adenomatous polyps with severe dysplasia. Journal of Gastroenterology 32:4, pages 492-495.
Crossref
Crossref
John R. Feussner, Eugene Z. Oddone & Jeffrey G. Wong. 1997. Geriatric Medicine. Geriatric Medicine
231
247
.
Jack D Hardcastle, Jocelyn O Chamberlain, Michael HE Robinson, Susan M Moss, Satya S Amar, Tom W Balfour, Peter D James & Christine M Mangham. (1996) Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. The Lancet 348:9040, pages 1472-1477.
Crossref
Crossref
Hiroshi Saito. (2005) Screening for Colorectal Cancer by Immunochemical Fecal Occult Blood Testing. Japanese Journal of Cancer Research 87:10, pages 1011-1024.
Crossref
Crossref
A.R. Hart, B. Jestico, C. Antill, M. Taylor & J.F. Mayberry. (1996) Blood donor centres can effectively publicise cancer screening. Public Health 110:4, pages 247-249.
Crossref
Crossref
David F. Ransohoff & Christopher A. Lang. (1996) Improving the Fecal Occult-Blood Test. New England Journal of Medicine 334:3, pages 189-190.
Crossref
Crossref
Gabriel A. KuneGabriel A. Kune. 1996. Causes and Control of Colorectal Cancer. Causes and Control of Colorectal Cancer
287
334
.
Jack S. Mandel. 1996. Advances in Cancer Screening. Advances in Cancer Screening
51
76
.
Jocelyn Chamberlain. 1996. Evaluation of Cancer Screening. Evaluation of Cancer Screening
55
75
.
SIDNEY J. WINAWER. (1995) Can Mortality from Colorectal Cancer Be Reduced?. Annals of the New York Academy of Sciences 768:1, pages 60-67.
Crossref
Crossref
DeAnn Lazovich, Noel S Weiss, Nancy G Stevens, Emily White, Barbara McKnight & Edward H Wagner. (2016) A Case-Control Study to Evaluate Efficacy-Of Screening for Faecal Occult Blood. Journal of Medical Screening 2:2, pages 84-89.
Crossref
Crossref
M.H.E. Robinson, C.G. Marks, P.A. Farrands, D.K. Whynes, K. Bpstock & J.D. Hardcastle. (1995) Is an immunological faecal occult blood test better than Haemoccult? A cost-benefit study. European Journal of Surgical Oncology (EJSO) 21:3, pages 261-264.
Crossref
Crossref
M H E Robinsno, S M Moss, J D Hardcastle, D K Whynes, J O Chamberlain & C M Mangham. (2016) Effect of Retesting with Dietary Restriction in Haemoccult Screening for Colorectal Cancer. Journal of Medical Screening 2:1, pages 41-44.
Crossref
Crossref
Bernie Towler, Les Irwig, Paul Glasziou, Marion Haas, Angela Plunkett & Glenn Salkeld. (2010) The potential benefits and harms of screening for colorectal cancer. Australian Journal of Public Health 19:1, pages 24-28.
Crossref
Crossref
A R Hart, T L Barone, A C B Wicks & J F Mayberry. (2022) National Industry's Interest in Colorectal Cancer Screening Programmes. Journal of the Royal Society of Medicine 87:11, pages 652-654.
Crossref
Crossref
Ann Tabor, Flemming R Jensen, Johannes E Bock & Claus K Høgdall. (2016) Feasibility Study of a Randomised Trial of Ovarian Cancer Screening. Journal of Medical Screening 1:4, pages 215-219.
Crossref
Crossref
John D. Freedman & Charlene K. Mitchell. (1994) A simple strategy to improve patient adherence to outpatient fecal occult blood testing. Journal of General Internal Medicine 9:8, pages 462-464.
Crossref
Crossref
Hidenori Nakama. (2016) A Comparative Study on the Efficacy of a Mass Screening Program for Colorectal Cancer — Comparison Between Cancer Cases Detected by Mass Screening and by Outpatient Clinics. Asia Pacific Journal of Public Health 7:3, pages 159-164.
Crossref
Crossref
Raymond Y. Demers & Kenneth C. Parsons. (2007) Colorectal cancer incidence in pattern and model makers: Evidence from a screening program. American Journal of Industrial Medicine 26:1, pages 33-45.
Crossref
Crossref
Julie King, Gregory Fairbrother, Cristina Thompson & David L. Morris. (2010) Influence of socioeconomic status, ethnicity and an educational brochure on compliance with a postal faecal occult blood test. Australian Journal of Public Health 18:1, pages 87-92.
Crossref
Crossref
J. Olsen, J. Lynggaard, O. Kronborg & M. Ewertz. (1994) Dietary risk factors for cancer and adenomas of the large intestine. A case-control study within a screening trial in Denmark. European Journal of Cancer 30:1, pages 53-60.
Crossref
Crossref
M.H.Z. Labib & B.J.M. Jones. 1994. Scientific Foundations of Biochemistry in Clinical Practice. Scientific Foundations of Biochemistry in Clinical Practice
347
382
.
Nobuo Hiwatashi, Tomizo Morimoto, Akira Fukao, Hirofusa Sato, Nobuyuki Sugahara, Shigeru Hisamichi & Takayoshi Toyota. (2005) An Evaluation of Mass Screening Using Fecal Occult Blood Test for Colorectal Cancer in Japan: A Case‐Control Study. Japanese Journal of Cancer Research 84:11, pages 1110-1112.
Crossref
Crossref
A R Hart, A C B Wicks & J F Mayberry. (2022) A Survey of Industries and Colorectal Cancer Screening of Employees in the East Midlands of England. Journal of the Royal Society of Medicine 86:10, pages 571-572.
Crossref
Crossref
M.H.E. Robinson, D.P. Berry, K.D. Vellacott, V. Moshakis & J.D. Hardcastle. (1993) Screening for colorectal cancer. The Lancet 342:8865, pages 241.
Crossref
Crossref
Jack S. Mandel, John H. Bond, Timothy R. Church, Dale C. Snover, G. Mary Bradley, Leonard M. Schuman & Fred Ederer. (1993) Reducing Mortality from Colorectal Cancer by Screening for Fecal Occult Blood. New England Journal of Medicine 328:19, pages 1365-1371.
Crossref
Crossref
W.S. Atkin, J.M.A. Northover, J. Cuzick & D.K. Whynes. (1993) Prevention of colorectal cancer by once-only sigmoidoscopy. The Lancet 341:8847, pages 736-740.
Crossref
Crossref
C Hall, J Griffin, P W Dykes, J A Williams & M R Keighley. (1993) Haemoccult does not reduce the need for colonoscopy in surveillance after curative resection for colorectal cancer.. Gut 34:2, pages 227-229.
Crossref
Crossref
D K Whynes, A R Walker & J D Hardcastle. (1992) Effect of subject age on costs of screening for colorectal cancer.. Journal of Epidemiology & Community Health 46:6, pages 577-581.
Crossref
Crossref
Julie King, Gregory Fairbrother, Cristina Thompson & David L. Morris. (2010) COLORECTAL CANCER SCREENING: OPTIMAL COMPLIANCE WITH POSTAL FAECAL OCCULT BLOOD TEST. Australian and New Zealand Journal of Surgery 62:9, pages 714-719.
Crossref
Crossref
Tim Byers & Robin Gorsky. (1992) Estimates of costs and effects of screening for colorectal cancer in the united states. Cancer 70:S3, pages 1288-1295.
Crossref
Crossref
Charles R. Smart. (1992) Screening and early diagnosis. Cancer 70:S3, pages 1246-1251.
Crossref
Crossref
David K. Whynes, Andrew R. Walker & Jack D. Hardcastle. (2006) Cost savings in mass population screening for colorectal cancer resulting from the early detection and excision of adenomas. Health Economics 1:1, pages 53-60.
Crossref
Crossref
Mark T Petty, Melissa C Deacon, Masha A Alexeyeff, D James B St John & Graeme P Young. (1992) Readability and sensitivity of a new faecal occult blood test in a hospital ward environment: Comparison with an established test. Medical Journal of Australia 156:6, pages 420-423.
Crossref
Crossref
. (1992) Screening for Colorectal Cancer. New England Journal of Medicine 326:2, pages 134-137.
Crossref
Crossref
Rémy Meier & Klaus Gyr. 1992. Familial Cancer Control. Familial Cancer Control
53
57
.
J. D. HARDCASTLE. (2008) Screening average risk individuals. Journal of Gastroenterology and Hepatology 6:6, pages 545-547.
Crossref
Crossref
Jane F. Desforges, David F. Ransohoff & Christopher A. Lang. (1991) Screening for Colorectal Cancer. New England Journal of Medicine 325:1, pages 37-41.
Crossref
Crossref
Andrew Walker & David K. Whynes. (1991) Participation and screening programmes for colorectal cancer: More would be better?. Journal of Health Economics 10:2, pages 207-225.
Crossref
Crossref
Carlo La Vecchia, Fabio Levi, Silvia Franceschi & Peter Boyle. (2009) Assessment of Screening for Cancer. International Journal of Technology Assessment in Health Care 7:3, pages 275-285.
Crossref
Crossref
Karsten Bech, Ole Kronborg & Claus Fenger. (1991) Adenomas and hyperplastic polyps in screening studies. World Journal of Surgery 15:1, pages 7-13.
Crossref
Crossref
Jerome J. DeCosse. (1990) Invited commentary. World Journal of Surgery 14:5, pages 652-653.
Crossref
Crossref
Michael Agrez, David Evans & John Duggan. (2008) FAECAL OCCULT BLOOD TESTING FOR COLORECTAL CANCER: LUXURY OR NECESSITY?. Australian and New Zealand Journal of Surgery 60:6, pages 451-454.
Crossref
Crossref
J. D. Kettner, C. Whatrup, J. E. C. W. Verne, K. Young, C. B. Williams & J. M. A. Northover. (1990) Is there a preference for different ways of performing faecal occult blood tests?. International Journal of Colorectal Disease 5:2, pages 82-86.
Crossref
Crossref
J. Faivre. (1990) Le dèpistage de masse du cancer colorectal: bientôt une réalité?Will screening for colorectal cancer soon become a reality?Despistaje de masa del cancer colorrectal: ¿ Una realidad cercana?. Acta Endoscopica 20:1, pages 1-4.
Crossref
Crossref
J.D. Hardcastle & W.M. Thomas. (1989) Screening an asymptomatic population for colorectal cancer. Baillière's Clinical Gastroenterology 3:3, pages 543-566.
Crossref
Crossref
J.D Hardcastle, J Chamberlain, J Sheffield, T.W Balfour, N.C Armitage, W.M Thomas, G Pye, P.D James, S.S Amar & S.M Moss. (1989) RANDOMISED, CONTROLLED TRIAL OF FAECAL OCCULT BLOOD SCREENING FOR COLORECTAL CANCER. The Lancet 333:8648, pages 1160-1164.
Crossref
Crossref
Jack D. Hardcastle & Geoffrey Pye. (1989) Screening for colorectal cancer: A critical review. World Journal of Surgery 13:1, pages 38-44.
Crossref
Crossref
Glenn H. Lytle. (2006) Screening for colorectal carcinoma. Seminars in Surgical Oncology 5:3, pages 194-200.
Crossref
Crossref
Joseph L. Kinzie, Ann L. Silverman, Tej P. Gupta & Rene R. Peleman. (1988) Screening and Surveillance for Colorectal Cancer. Gastroenterology Clinics of North America 17:4, pages 793-809.
Crossref
Crossref
W. Rösch. 1988. 94. Kongreß. 94. Kongreß
15
18
.